Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 13.945 0.295 (2.16%) Market Cap: 1.34 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 19.10 GF Score: 43/100

Q4 2019 Avadel Pharmaceuticals PLC Earnings Call Transcript

Mar 12, 2020 / 12:30PM GMT
Release Date Price: $6.35 (-20.53%)
Operator

Greetings, and welcome to the Avadel Pharmaceuticals Fourth Quarter Year-end Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Tom McHugh, Chief Financial Officer of Avadel. Thank you, Mr. McHugh, you may begin.

Thomas S. McHugh
Avadel Pharmaceuticals plc - CFO

Thank you, and good morning, and thank you for joining us on our conference call. This morning, we issued our fourth quarter and year-end financial results news release, and this release can be found on our website at www.avadel.com.

As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot